These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 20643572)

  • 21. Antibody-drug conjugates as targeted cancer therapeutics.
    Sun Y; Yu F; Sun BW
    Yao Xue Xue Bao; 2009 Sep; 44(9):943-52. PubMed ID: 20055167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody-drug conjugates as novel anti-cancer chemotherapeutics.
    Peters C; Brown S
    Biosci Rep; 2015 Jun; 35(4):. PubMed ID: 26182432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody-drug conjugates for cancer: poised to deliver?
    Hughes B
    Nat Rev Drug Discov; 2010 Sep; 9(9):665-7. PubMed ID: 20811367
    [No Abstract]   [Full Text] [Related]  

  • 24. [Progress in the study of drug delivery system based on nanoparticles to overcome multi-drug resistance].
    Chen JN; Shen Q; Li SS
    Yao Xue Xue Bao; 2009 Apr; 44(4):333-7. PubMed ID: 19545047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current Phase II antibody-drug conjugates for the treatment of lymphoid malignancies.
    Robak T; Robak E
    Expert Opin Investig Drugs; 2014 Jul; 23(7):911-24. PubMed ID: 24708159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inotuzumab ozogamicin as novel therapy in lymphomas.
    Wong BY; Dang NH
    Expert Opin Biol Ther; 2010 Aug; 10(8):1251-8. PubMed ID: 20528256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD70 as a therapeutic target in human malignancies.
    Grewal IS
    Expert Opin Ther Targets; 2008 Mar; 12(3):341-51. PubMed ID: 18269343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody-drug conjugates (ADCs) for cancer therapy: Strategies, challenges, and successes.
    Abdollahpour-Alitappeh M; Lotfinia M; Gharibi T; Mardaneh J; Farhadihosseinabadi B; Larki P; Faghfourian B; Sepehr KS; Abbaszadeh-Goudarzi K; Abbaszadeh-Goudarzi G; Johari B; Zali MR; Bagheri N
    J Cell Physiol; 2019 May; 234(5):5628-5642. PubMed ID: 30478951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanoparticle technologies for cancer therapy.
    Alexis F; Pridgen EM; Langer R; Farokhzad OC
    Handb Exp Pharmacol; 2010; (197):55-86. PubMed ID: 20217526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Localized delivery of anti-cancer drugs by electroporation.
    Featherstone C
    Mol Med Today; 1998 Feb; 4(2):47. PubMed ID: 9547785
    [No Abstract]   [Full Text] [Related]  

  • 31. Small molecule-drug conjugates: A novel strategy for cancer-targeted treatment.
    Zhuang C; Guan X; Ma H; Cong H; Zhang W; Miao Z
    Eur J Med Chem; 2019 Feb; 163():883-895. PubMed ID: 30580240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Linked-in: design and efficacy of antibody drug conjugates in oncology.
    Feld J; Barta SK; Schinke C; Braunschweig I; Zhou Y; Verma AK
    Oncotarget; 2013 Mar; 4(3):397-412. PubMed ID: 23651630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and biological evaluation of novel taxoids designed for targeted delivery to tumors.
    Baloglu E; Miller ML; Roller EE; Cavanagh EE; Leece BA; Goldmacher VS; Chari RV
    Bioorg Med Chem Lett; 2004 Dec; 14(23):5885-8. PubMed ID: 15501062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumour-targeted drug and gene delivery: principles and concepts.
    Cassidy J; Schätzlein AG
    Expert Rev Mol Med; 2004 Sep; 6(19):1-17. PubMed ID: 15387893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody-cytotoxic agent conjugates for cancer therapy.
    Chen J; Jaracz S; Zhao X; Chen S; Ojima I
    Expert Opin Drug Deliv; 2005 Sep; 2(5):873-90. PubMed ID: 16296784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delivery of anticancer drugs.
    Zee-Cheng RK; Cheng CC
    Methods Find Exp Clin Pharmacol; 1989; 11(7-8):439-529. PubMed ID: 2689812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of potent monoclonal antibody auristatin conjugates for cancer therapy.
    Doronina SO; Toki BE; Torgov MY; Mendelsohn BA; Cerveny CG; Chace DF; DeBlanc RL; Gearing RP; Bovee TD; Siegall CB; Francisco JA; Wahl AF; Meyer DL; Senter PD
    Nat Biotechnol; 2003 Jul; 21(7):778-84. PubMed ID: 12778055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody-drug conjugates: the new generation of biotechnological therapies against cancer.
    Melgarejo-Rubio G; Pérez-Tapia SM; Medina-Rivero E; Velasco-Velázquez MA
    Gac Med Mex; 2020; 156(3):228-235. PubMed ID: 32538994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiation-guided drug delivery systems.
    Stacy DR; Lu B; Hallahan DE
    Expert Rev Anticancer Ther; 2004 Apr; 4(2):283-8. PubMed ID: 15056058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug-conjugated monoclonal antibodies for the treatment of cancer.
    Lambert JM
    Curr Opin Pharmacol; 2005 Oct; 5(5):543-9. PubMed ID: 16087399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.